Microbot Medical Inc. (NASDAQ:MBOT) Short Interest Up 80.0% in December

Microbot Medical Inc. (NASDAQ:MBOT) was the target of a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 1,040,000 shares, a growth of 80.0% from the December 15th total of 577,700 shares. Based on an average trading volume of 2,030,000 shares, the days-to-cover ratio is presently 0.5 days.

Microbot Medical Stock Down 7.6 %

MBOT traded down $0.14 during trading on Friday, reaching $1.65. 2,136,073 shares of the stock traded hands, compared to its average volume of 11,616,517. The stock’s 50-day moving average is $1.19 and its 200 day moving average is $1.05. Microbot Medical has a 12 month low of $0.82 and a 12 month high of $3.38. The stock has a market capitalization of $33.29 million, a PE ratio of -2.05 and a beta of 1.46.

Institutional Investors Weigh In On Microbot Medical

A hedge fund recently bought a new stake in Microbot Medical stock. Thoroughbred Financial Services LLC purchased a new position in shares of Microbot Medical Inc. (NASDAQ:MBOT) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 52,250 shares of the biotechnology company’s stock, valued at approximately $53,000. Thoroughbred Financial Services LLC owned about 0.33% of Microbot Medical as of its most recent SEC filing. 16.30% of the stock is currently owned by institutional investors and hedge funds.

About Microbot Medical

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.